MedTrace Logo

Exploring the Therapeutic Effects of Creatine Supplementation for Long COVID-19

NCT06992414 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2025-05-31

No results posted yet for this study

Summary

Individuals living with Long COVID often experiencing a degree of undue fatigue after physical or cognitive exertion secondary to the condition, timed post-exertional malaise 9PEM). This trial aims to explore the efficacy of creatine monohydrate in managing PEM

Conditions

  • Long COVID Fatigue

Interventions

DIETARY_SUPPLEMENT

Creatine monohydrate

8 g/day creatine monohydrate powder

Sponsors & Collaborators

  • University of Calgary

    lead OTHER

Principal Investigators

  • Keely A Shaw, PhD · University of Calgary

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-02
Primary Completion
2026-06-30
Completion
2026-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06992414 on ClinicalTrials.gov